Effect of N(ω)-nitro-L-arginine methyl ester, a nitric oxide synthesis inhibitor, on stress- and morphine-induced prolactin release in male rats

British Journal of Pharmacology

Volumn 120, Issue 2, 1997, Pages 268-272

  Matton, A ^a   Bollengier, F ^a   Finne E ^a   Vanhaelst, L ^a  

^a FACULTY OF MEDICINE AND PHARMACY   (Belgium)

Author keywords

Morphine; N( ) nitro L arginine methyl ester (L NAME); Nitric oxide (NO); Opiate; Opioid; Prolactin (PRL); Stress

Indexed keywords

MORPHINE; N(G) NITROARGININE METHYL ESTER; PROLACTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DOSE RESPONSE; INDWELLING CATHETER; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; JUGULAR VEIN; MALE; NONHUMAN; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTIN RELEASE; RAT; STRESS;

ANIMALS; CYCLIC AMP; ENZYME INHIBITORS; MALE; MORPHINE; NARCOTICS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PROLACTIN; RATS; RATS, WISTAR; STRESS;

EID: 0031028054     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0700899     Document Type: Article

References (32)

1. AGHAJANIAN, G.K., KOGAN, J.H. & MOGHADDAM, B. (1994). Opiate withdrawal increases glutamate and aspartate efflux in the locus coeruleus: an in vivo microdialysis study. Brain Res., 636, 126-130.
2. AKAOKA, H. & ASTON-JONES, G. (1991). Opiate withdrawal-induced hyperactivity of locus coeruleus neurons is substantially mediated by augmented excitatory amino acid input. J. Neurosci., 11, 3830-3839.
3. BEN-ELIYAHU, S., MAREK, P., VACCARINO, A.L., MOGIL, J.S., STERNBERG, W.F. & LIEBESKIND, J.C. (1992). The NMDA receptor antagonist MK-801 prevents long-lasting non-associative morphine tolerance in the rat. Brain Res., 57, 304-308.
4. BOLLENGIER, F., ESPEEL, M., MATTON, A., MAHLER, A. & VANHAELST, L. (1995). Secretion of 23 kDa and glycosylated prolactin by rat pituitary cell culture: a comparative morphological, cyto and immunochemical study. Endocrine, 3, 61-68.
5. BRUNI, J.F., VAN VUGT, D., MARSHALL, S. & MEITES, J. (1977). Effects of naloxone, morphine and methionine enkephalin on serum prolactin, luteinizing hormone, follicle stimulating hormone, thyroid stimulating hormone and growth hormone. Life Sci., 21, 461-466.
6. CHILDERS, S.R (1991). Opioid receptor coupled second messenger systems. Life Sci., 48, 1991-2003.
7. GALLY, J.A., MONTAGUE, P.R., REEKE, G.N. Jr. & EDELMAN, G.M. (1990). The NO hypothesis: possible effects of a short-lived rapidly diffusible signal in the development and function of the nervous system. Proc. Natl. Acad. Sci. U.S.A., 87, 3547-3551.
8. GARTHWAITE, J. & BOULTON, C.L. (1995). Nitric oxide signalling in the central nervous system. Ann. Rev. Physiol., 57, 683-706.
9. GARTHWAITE, J. (1991). Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci., 14, 60-67.
10. HARMS, P.G. & OJEDA, S.R. (1974). A rapid and simple procedure for chronic cannulation of the rat jugular vein. Life Sci., 38, 987-992.
11. HERZ, A. (1984). Multiple opioid receptors. In Opioid Modulation of Endocrine Function ed. Delitala, G., Motta, M. & Serio, M., pp. 11-19. New York: Raven Press.
12. HONG, M., MILNE, B. & JHAMANDAS, K. (1993). Evidence for the involvement of excitatory amino acid pathways in the development of precipitated withdrawal from acute and chronic morphine: an in vivo voltammetric study in the rat locus coeruleus Brain Res., 623, 131-141.
13. KNOWLES, R.G., PALACIOS, M., PALMER, R.M.J. & MONCADA, S. (1989). Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proc. Natl. Acad. Sci. U.S.A. 86, 5159-5162.
14. G-nitro-L-arginine prevents morphine tolerance. Eur. J. Pharmacol., 221, 399-400.
15. KOLESNIKOV, Y.A., PICK, C.G. & PASTERNAK, G.W. (1993). Blockade of tolerance to morphine but not to κ-opioids by a nitric oxide synthase inhibitor. Proc. Natl. Acad. Sci. U.S.A., 90, 5162-5166.
16. MAREK, P., BEN-ELIYAHU, S., GOLD, M. & LIEBESKIND, J.C. (1991). Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat. Brain Res., 547, 77-81.
17. MATTON, A., BUYDENS, P., FINNE, E., GOVAERTS, J. & VAN-HAELST, L. (1991). Analysis of the receptor specificity of tolerance induction in stress versus opioid-related prolactin secretion in rats. J. Endocrinol., 128, 281-285.
18. NESTLER, E.J. (1992). Molecular mechanisms of drug addiction. J. Neurosci., 12, 2439-2450.
19. PRZEWLOCKI, R., MACHELSKA, H. & PRZEWLOCKA, B. (1993). Inhibition of nitric oxide synthase enhances morphine antinociception in the rat spinal cord. Life Sci., 53, PL1-5.
20. RAGAVAN, V.V. & FRANTZ, A.G. (1981). Opioid regulation of prolactin secretion: evidence for a specific role of β-endorphin. Endocrinology, 109, 1769-1771.
21. RAUHALA, P., IDÄNPÄÄN-HEIKKILÄ, J.J., TUOMINEN, R.K. & MÄNNISTÖ, P.T. (1994). N-nitro-L-arginine attenuates development of tolerance to antinociceptive but not to hormonal effects of morphine. Eur. J. Pharmacol., 259, 57-64.
22. SAMSON, W.K., MCDONALD, J.K., LUMPKIN, M.D. (1985). Naloxone-induced dissociated of oxytocin and prolactin releases. Neuroendocrinology, 40, 68-71.
23. SCHUMAN, E.M. & MADISON, D.V. (1994). Nitric oxide and synaptic function. Ann. Rev. Neurosci., 17, 153-183.
24. SIEGEL, R.A., CHOWERS, J., CONFORTI, N. & WEIDENFELD, J. (1982). Effects of naloxone on basal and stress-induced prolactin secretion, in intact, hypothalamic deafferented, adrenalectomized, and dexamethasone pretreated male rats. Life Sci., 30, 1691-1699.
25. SNYDER, S.H. & BREDT, D.S. (1991). Nitric oxide as a neuronal messenger. Trends Pharmacol. Sci., 12, 125-128.
26. THORAT, S.N., REDDY, P.L. & BHARGAVA, H.N. (1993). Evidence for the role of nitric oxide in κ-opiate tolerance in mice. Brain Res., 621, 171-174.
27. TISEO, P.J. & INTURRISI, C.E. (1993). Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-aspartale receptor antagonist LY274614. J. Pharmacol. Exp. Ther., 264, 1090-1096.
28. TOCCO, G., SHORS, T.J., BAUDRY, M. & THOMPSON, R.F. (1991). Selective increase of AMPA binding to the AMPA/quisqualate receptor in the hippocampus in response to acute stress. Brain Res., 559, 168-171.
29. TRUJILLO, K.A. & AKIL, H. (1991). Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science, 251, 85-87.
30. VAN VUGT, D.A., BRUNI, J.F. & MEITES, J. (1978). Naloxore inhibition of stress-induced increase in prolactin secretion. Life Sci., 22, 85-90.
31. XU, J.Y. & TSENG, L.F. (1995). Nitric oxide/cyclic guanosine monophosphate system in the spinal cord differentially modulates intracerebroventricularly administered morphine- and β-endorphin-induced antinociception in the mouse. J. Pharmacol. Exp. Ther., 274, 8-16.
32. ZHUO, M., KANDEL, E.R. & HAWKlNS, R.D. (1994). Nitric oxide and cGMP can produce either synaptic depression or potentiation depending on the frequency of presynaptic stimulation in the hippocampus. NeuroReport, 5, 1033-1036.